Invitation to the EBAC-accredited Satellite Symposium "Managing hypertrophic cardiomyopathy in clinical practice: The patient journey"

For more information, please visit the ESC website.

Educational objectives

The educational objectives of the symposium are to:

•    Recognize patient cases that warrant an HCM-focused diagnostic strategy
•    Analyze the latest clinical data regarding the use of myosin inhibitors in the treatment of HCM
•    Discuss the evidence supporting and recommendations of recently published guidelines on HCM

Agenda

10:00 – 10:05     Introduction with a case of a patient with HCM - Perry Elliott, MD, PhD - London, United Kingdom

10:05 – 10:15     What are the challenges in making the right diagnosis? - Perry Elliott, MD, PhD - London, United Kingdom

10:15 – 10:25     Understanding the etiology of HCM and pathways for intervention - Roberto Barriales-Villa, MD, PhD - A Coruña, Spain

10:25 – 10:35     The clinical challenge of managing a patient with HCM - Iacopo Olivotto, MD - Florence, Italy

10:35 – 10:45     Panel discussion and Q&A - All faculty

CME Accreditation

This programme is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) with 45 minutes effective education time.  Each participant should claim only those hours of credit that have actually been spent in the educational activity. The Accreditation Council for Continuing Medical Education (ACCME®) and EBAC have recognized each other’s accreditation systems as substantially equivalent.

Funding

This symposium is supported by an unrestricted educational grant from Bristol Myers Squibb.